Abstracts & Posters 2024

O1	Differing effects of TDF versus TAF on duodenal mucosa may explain their different effects on body weight and plasma lipid concentrations Sutinen et al.
O2	People Living with HIV Exhibit Distinct HIV DNA Distribution in Gut Tissues Relative to Gut Damage Hanne Gullaksen, Malin Holm Meyer-Myklestad
O3	Physical, psychosocial and sexual health among people aged 50 years and above, with and without HIV, in Denmark: a cross-sectional nationwide study Scofield et al.
O4	The Impact of two-year Metformin treatment on CD4 T Cell Count and CD4/CD8 Ratio in People Living with HIV: A Retrospective Cohort Study Bäckdahl et al.
O5	Distinct transcriptomic signatures of immune cells characterise disease control in patients with chronic hepatitis B Apol et al.
O6	Hepatic flares after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B: results from the Nuc-Stop Study Holmberg et al.
P1	The prevalence and characteristics of hepatitis B/D in 48,522 HBsAg tested individuals in Mongolia Jargalsaikhan, Habiba Khodir Kamal et al.
P2	Public Knowledge and Attitudes on HIV/AIDS in the U=U Era: Insights from a Nordic Survey Study Moseholm et al.
P3	Impact of BK polyomavirus origin in kidney transplant recipients Zigmantaviciute et al.
P4	Safety and efficacy of WG-am, an innovative microbicide with dual HIV-1 inhibition derived from elite controllers Cena-Diez et al.
P5	Withdrawn
P6	Rapid isolation of monoclonal antibodies that potently cross-neutralize Influenza A virus group 1 variants Fischer et al.
P7	High prevalence of Hepatic Steatosis in a cohort of People Living With HIV: exploring the role of metabolic and HIV-related factors Panza et al.
P8	Multiple pro-viral effects of the host protein G3BP in SARS-CoV-2 Infection Long et al.
P9	RESPONDing to Contemporary Challenges for People Living with HIV: An Evolving Cohort Collaboration Neesgaard et al.
P10	Pan-Caspase Inhibitors Induce HIV-1 Latency Reversal through Lymphotoxin-α Secretion by Cytokine-Primed NK Cells Hajikhezri et al.
P11	Using Next-Generation Sequencing for HIV-1 drug resistance genotyping Strålfors et al.
P12	No evidence of neuronal injury after switching to dolutegravir/lamivudine from three-drug regimen Renborg et al.
P13	Evaluation of antiviral activity of dipeptide tryptophylglycine-amid (WG) against HIV-1 isolates harboring gp120 resistance-associated mutations Giammarino et al.
P14	Treatment burden and regimen fatigue among patients with HIV and diabetes attending clinics of Tikur Anbessa specialized hospital Muhammed et al.
P15	Phenotypic characterization of untreated chronic hepatitis B infected individuals in an Ethiopian cohort using fixed whole blood samples MacLeod et al.
P16	Differences in SARS-CoV-2 vaccine uptake among people living with HIV compared to people without HIV: a nationwide register-study in Sweden Killander Möller et al.
P17	Using unsupervised machine learning methods of analysis for feature selection in cancer risk prediction model development: a study protocol Nilsson et al.
P18	Long-term follow up of mRNA COVID-19 vaccinations reveals persistent gap between natural and hybrid immunity due to breakthrough infections Marklund et al.
P19	Impaired adherence and higher prevalence of antiretroviral treatment side-effects in migrants living with HIV in Sweden Mellgren et al.
P20	People living with HIV’s perspectives on Patient Reported Outcome (PRO) use in Danish HIV care A qualitative focus group discussion and interview study Borchmann et al.
P21	Hepatitis C testing and treatment for people who inject drugs in Iceland: results from a nurse-led outreach initiative Tómasdóttir et al.